Author: spadmin

ContourGlobal clôture un financement innovant auprès d’OPIC et d’IFC autour du projet électrique de Cap des Biches, et annonce une extension de 32 MW

– Une structure de financement innovante basée sur un financement d’IFC sur 18 ans par swap dollar américain/euro de 91 millions $ d’OPIC – ContourGlobal et la Société Nationale d’Electricité (Senelec) acceptent de rapidement ajouter une capacité supplémentaire de 32 MW sur le site existant – Le projet Cap des Biches d’une capacité combinée de 85 MW et d’une valeur […]

ContourGlobal Closes Innovative Financing with OPIC and IFC for Cap des Biches Power Project and Announces 32 MW Extension

– Innovative Financing Structure Sees IFC Swap 18-year $91 million OPIC USD Financing to Euros – ContourGlobal and Societe Nationale d’Electricite (Senelec) Agree to rapidly add an additional 32 MW to the existing site – Combined 85 MW, $165 million Cap des Biches Project Will Provide Electric Power to 100,000 Senegalese NEW YORK and DAKAR, Senegal, […]

Avisa’s Biomarker Breath Test Detects Tuberculosis in South Africa Pilot Study

Avisa Pharma Inc. announced today that it successfully detected active TB in a pilot study in Durban, South Africa. The study had three cohorts, suspected TB subjects who were HIV negative, suspected TB subjects who were HIV positive and controls. The AV-BreathTest™ detected TB in both HIV+ and HIV- cohorts confirmed by PCR and standard TB culture. The AV-BreathTest™ measures the whole lung, in vivo, does not require sputum, and is point-of-care. The time from test initiation to result is less than 10 minutes, and the breath test has the potential to monitor antibiotic therapy. There are 9.5 million active TB cases worldwide, of which 1 million are children who have difficulty producing sputum and require traditional tests with more invasive procedures.

According to David S. Joseph, Avisa’s President and CEO, “This pilot study allows us to plan our pivotal clinical trials to be held in 2017 on multiple continents for regulatory approvals. Early screening triage and detection by our breath test biomarker can substantially reduce the spread of this terrible disease; reduce the need for time-consuming, low-sensitivity smear microscopy; and identify active TB in those patients with symptoms that have difficulty in producing sputum for culture or PCR detection. Moreover, since the test is less than 10 minutes, monitoring efficacy of antibiotic therapy is another potential benefit of our technology given the major concern of multidrug resistance.”


Avisa is a clinical stage company that is developing an exciting, next-generation biomarker platform technology that enables the rapid detection of a variety of respiratory pathogens within minutes after the patient inhales its proprietary drug substrate, AV-U13. Upon receipt of its first FDA approval, the company plans to initiate additional clinical studies for ventilator associated pneumonia (VAP), chronic obstructive pulmonary disease (COPD), healthcare acquired pneumonia (HCAP) and cystic fibrosis (CF). The company believes early detection will lead to lower healthcare costs. Avisa licensed its core breath test technology with the University of New Mexico’s Science Technology Center (UNM-STC). Avisa has its AVISAR SPEC™ laser spectrometer under development that incorporates major design advancements – a point-of-care, laptop size, 3 in. height, battery powered device that can fit into a backpack for rural health clinics in high burden countries, outpatient clinics, hospital inpatient and ICU/CCU units, emergency departments, urgent care centers, retail clinics and long term care facilities.


Avisa Pharma, Inc.

David Joseph, 505-820-1400

fax: 505-226-1500

Source: Avisa

Research and Markets: Global Photovoltaic Market Analysis – Trends, Strategies & Forecast to 2020 – Projected to Reach $350 Million by 2020

Research and Markets ( has announced the addition of the “Global Photovoltaic Market Analysis – Trends, Strategies & Forecast to 2020” report to their offering.

“Global Photovoltaic Market Analysis – Trends, Strategies & Forecast to 2020”

Tweet this

The Photovoltaic Market is poised to grow at a CAGR of more than 17% in the next 5 years to reach approximately $350 million by 2020.

This industry report analyzes the global markets for Photovoltaic Market across all the given segments in the research scope. The report focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and strategies. The report provides comprehensive market analysis across four major geographies such as North America, Europe, Asia Pacific and Other parts of the world.

A special focus has been made on 17 countries such as U.S., Canada, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary research and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Report Highlights:

Market trends observed since past 5 years

Forecasted market size till 2020, using estimated market values as the base numbers

Key market trends across the business segments and various geographies

Key developments and strategies observed in the market

In-depth profiling of major players and upcoming prominent players

Market opportunities and recommendations for new investments

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Photovoltaic market by Component

5 Photovoltaic market by Type

6 Photovoltaic market by Application

7 Photovoltaic market by Geography

8 Leading Companies

Companies Mentioned:

Canadian Solar

JA solar Co. Ltd

Kaneka Corporation

Kyocera Corporation

Mitsubishi Electric Corporation

Panasonic Corporation

ReneSola Co. Ltd

Trina Solar

Yingli Green

For more information visit


Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Sector: Photovoltaics

Source: Research and Markets

Utilisation des services financiers mobiles : une enquête du CGAP établit des données de référence au Rwanda et au Ghana

WASHINGTON, 16 décembre 2015 /PRNewswire/ — Les données d’une nouvelle enquête du CGAP sur l’inclusion financière donnent un premier aperçu de l’utilisation des services financiers par téléphone mobile au Ghana et au Rwanda, où 17 % des adultes disposent de comptes bancaires mobiles en activité. Logo – Réalisée auprès d’un échantillon d’adultes représentatif à l’échelle nationale, […]